Form 8-K - Current report:
SEC Accession No. 0001641172-25-026245
Filing Date
2025-09-03
Accepted
2025-09-02 17:40:11
Documents
13
Period of Report
2025-09-02
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 39686
  Complete submission text file 0001641172-25-026245.txt   250669

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE celu-20250902.xsd EX-101.SCH 3891
3 XBRL DEFINITION FILE celu-20250902_def.xml EX-101.DEF 26798
4 XBRL LABEL FILE celu-20250902_lab.xml EX-101.LAB 37062
5 XBRL PRESENTATION FILE celu-20250902_pre.xml EX-101.PRE 25422
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 6104
Mailing Address 170 PARK AVE FLORHAM PARK NJ 07932
Business Address 170 PARK AVE FLORHAM PARK NJ 07932 (908) 768-2170
Celularity Inc (Filer) CIK: 0001752828 (see all company filings)

EIN.: 831702591 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38914 | Film No.: 251286782
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)